MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.

Yan Cq; YH Lu; Tang Sm; Fan Wx

ScienceGate Book Chapters

JOURNAL ARTICLE

MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.

Yan Cq YH Lu Tang Sm Fan Wx

Year: 2018 Journal: PubMed Vol: 22 (10)Pages: 2985-2990 Publisher: National Institutes of Health

Get Full-Text PDF Get Analytical Report

Abstract

MiR-519d can repress the proliferation, cycle, and invasion of prostate cancer PC3 cells by inhibiting NRBP1.

Keywords:

Cell cycle Vimentin Cyclin D1 Prostate cancer Cancer research Blot Cell growth Epithelial–mesenchymal transition Metastasis Cyclin D Chemistry Biology Cancer Immunohistochemistry Medicine Internal medicine Immunology Gene

Metrics

Cited By

1.36

FWCI (Field Weighted Citation Impact)

Refs

0.76

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Cancer, Lipids, and Metabolism

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Cancer-related molecular mechanisms research

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

MiR-519d inhibits prostate cancer cell proliferation, cycle and invasion via targeting NRBP1.

Abstract

Metrics

Citation History

Topics

Related Documents

miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2

miR-154 inhibits prostate cancer cell proliferation by targeting CCND2

miR-519d-3p Inhibits Cell Proliferation and Invasion of Gastric Cancer by Downregulating B-Cell Lymphoma 6

miR-1825 Accelerates Cell Proliferation and Inhibits Cell Apoptosis of Prostate Cancer via Targeting Suppressor of Cancer Cell Invasion

miR‐377‐5p inhibits lung cancer cell proliferation, invasion, and cell cycle progression by targeting AKT1 signaling